This Week: Prasad’s back, FDA considers COVID authorization, MAHA draft report leaked

This Week at FDAThis Week at FDABiologics/ biosimilars/ vaccinesGovernment/legislationLeadershipMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)